This list is based on the watchlists of people on Stock Events who follow 941.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include SONOVEIN, a robotic, non-surgical echotherapy system designed for addressing varicose veins, and ECHOPULSE, a similar robotic, non-invasive solution for treating thyroid nodules and breast fibroadenoma. Furthermore, the company provides EPack, a disposable component used during procedures to protect the patient's skin and enhance image clarity.
FAQs
What is Theraclion stock price today?▼
The current price of 941.STU is €0.67 EUR — it has decreased by -0.88% in the past 24 hours. Watch Theraclion stock price performance more closely on the chart.
What is Theraclion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Theraclion stocks are traded under the ticker 941.STU.
What is Theraclion market cap?▼
Today Theraclion has the market capitalization of 49.14M
When is the next Theraclion earnings date?▼
Theraclion is going to release the next earnings report on April 29, 2027.
What is Theraclion revenue for the last year?▼
Theraclion revenue for the last year amounts to 2.02M EUR.
What is Theraclion net income for the last year?▼
941.STU net income for the last year is -8.23M EUR.
How many employees does Theraclion have?▼
As of November 7, 2026, the company has 36 employees.
In which sector is Theraclion located?▼
Theraclion operates in the Health & Wellness sector.
When did Theraclion complete a stock split?▼
Theraclion has not had any recent stock splits.
Where is Theraclion headquartered?▼
Theraclion is headquartered in Malakoff, France.